期刊文献+

吡格列酮和非诺贝特在调节代谢综合征大鼠主动脉重构中的作用 被引量:5

Effect of Fenofibrate and Pioglitazone on Regulation of Arteriae Aorta Remodeling in the Metabolic Syndromic Rats
下载PDF
导出
摘要 目的探讨非诺贝特和吡格列酮对果糖饲养的代谢综合征大鼠主动脉重构的影响。方法用高果糖饮食饲养SD大鼠构建代谢综合征大鼠模型,分别单用非诺贝特或吡格列酮及二者合用干预。分析比较两种药物单用及合用干预后,代谢综合征大鼠在主动脉形态结构上的差异。结果非诺贝特和吡格列酮干预均可使代谢综合征大鼠主动脉内膜变平滑,抑制中膜平滑肌细胞增殖,使血管壁变薄;吡格列酮干预还使代谢综合征大鼠主动脉中膜平滑肌细胞及弹力纤维排列更为整齐。合用吡格列酮和非诺贝特干预,使主动脉结构更趋向于正常状态。结论非诺贝特和吡格列酮干预均可抑制代谢综合征大鼠主动脉的病理性重构;但单用非诺贝特作用不如单用吡格列酮明显;合用非诺贝特和吡格列酮,可通过不同的机制和作用靶点,产生协同作用,进一步改善及逆转代谢综合征状态下的血管重构,降低发生心血管疾病的危险性。 Aim To explore the effect of fenofibrate(Fen) and pioglitazone(Pio) on arteriae aorta remodeling in the fructose-induced metabolic syndromic(MS) Rats.Methods SD rats breeded with high fructose fed to raise MS rats,and Fen or Pio were used to intervent MS rats singly and jointly.The differences in arteriae aorta morphosis of MS rats were analyzed and compared among groups with different intervents.Results The arteriae aorta remodeling were amended in MS rats intervened by Fen and Pio.Relative to MS rats,rats intervened with Fen or Pio singly exhibited a more smoothing aortic tunica intima,less vascular medio-smooth muscle proliferation,and thinner vascular wall.Pio-intervention even displayed a more regular array of medio-smooth muscle cell and elastic fibers.Combination with fenofibrate and pioglitazone intervented MS rats,which built a more normal arteriae aorta in morphosis.Conclusions Intervention with fenofibrate or pioglitazone singly can restrain arteriae aorta pathologic remodeling in MS rats.The effectiveness of pioglitazone is more significant than that of fenofibrate.Synergistic effect of fenofibrate and pioglitazone can further improve and even reverse the vascular remodeling in MS rats by different mechanisms and acting targets.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2009年第12期966-970,共5页 Chinese Journal of Arteriosclerosis
基金 深圳市科技基金重点资助项目(200643)
关键词 代谢综合征 大鼠模型 血管重构 过氧化体增殖物激活型受体α/γ Metabolic Syndrome Rat Model Cardiovascular Remodeling Peroxisome Proliferator Activated Receptor-α/γ
  • 相关文献

参考文献14

  • 1Ramos F, Baglivo HP, Ramirez AJ, et al. The metabolic syndrome and related eardlovaseulaa risk [J].Curr Hypertens Rep, 2001 3 (2) : 100-106.
  • 2郑建清,周亦卿,林金秀.伴代谢综合征的高血压病患者动脉功能的变化[J].中国动脉硬化杂志,2009,17(4):315-317. 被引量:6
  • 3李东宝,华琦.过氧化体增殖物激活型受体基因变异与代谢综合征的相关性[J].中国动脉硬化杂志,2007,15(1):74-76. 被引量:2
  • 4Donnandy JA, Charbonnel B, Eckland DJA, et al.Secondary prevention of macrovasculm events in patients with type 2 diabetes in the PRO active sutdy ( PRO speetive pioglitazone clinical trial in macruvascular events):a randomised conu-olled trial [ J ]. Larwet, 2005,366 (9493) : 1 279-289.
  • 5Hanefeld M, Marx N, Pfutzner A, et al. Anti-inflammatory effects of plo-glitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the P1OSTAT Study [J]. J Am Coll Cardiol, 2007, 49 (3) : 290-297.
  • 6Keech A, Simes RJ, Barter P, et al. Effects of long-term fenoflbrate ther- apy on cardiovascular events in 9795 people with type 2 diabetes menitus (the FIELD study) : randomised controlled trial[J]. Lancet, 2005, 366: 1 849-861.
  • 7Nakagawa T, Hu H, ZhmSkov S, et al. A causal role for uric acid in fructose-induced metabolicc syndrome [J].Am J Physiol Renal Physiol, 2006, 290 (3) : 625-531.
  • 8闫振成,王利娟,钟健,聂海,曹廷兵,祝之明.过氧化物酶体增殖物激活受体在代谢综合征大鼠血管重构和功能改变中的作用[J].中华高血压杂志,2007,15(8):645-650. 被引量:4
  • 9Rayssiguierl Y, Gueux E, Nowacki W, et al. High fiuetose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation [J].Magnesium Research, 2006, 19 (4) : 237-243.
  • 10Sharabi Y, Oron-Herman M, Kamafi Y, et al. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons fiom the high fructose fed rat model [J].Am J Hypertens, 2007, 20 (2) : 206- 210.

二级参考文献63

共引文献9

同被引文献32

  • 1张旭升,张勇刚.尾加压素Ⅱ与冠心病[J].中国心血管病研究,2007,5(4):303-305. 被引量:5
  • 2Ambros V. The functions of animal microRNAs [ J]. Nature, 2004, 431 (7 006) : 350-355.
  • 3Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis [ J]. Br J Cancer, 2006, 94 (6) : 776-780.
  • 4Chen LJ,μLim SH, Yeh YT, et al. Roles of microRNAs in athero- sclerosis and restenosis [ J]. J Biomed Sci, 2012, 19( 1 ) : 79.
  • 5Han M, Toll J, Abdellatif M. MicroRNAs in the cardiovascular sys- tem[J]. Curr Opin Cardiol, 2011 , 26 (3) : 181-189.
  • 6Chen KC, Juo SH. MicroRNAs in atherosclerosis [ J]. Kaohsiung J Med Sci, 2012, 28(12): 631-640.
  • 7van Rooij E, Sutherland LB, Qi X, et al. Control of stress depend- ent cardiac growth and gene expression by a microRNA [ J]. Sci- ence, 2007, 316 (5 824) : 575-579.
  • 8Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells [ J]. Bio- chem Biophys Res Commun, 2010, 400 (2) : 236-240.
  • 9Wang YS, Wang HY, Liao YC, et aL. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimat for- mation [J]. Cardiovasc Res, 2012, 95(4): 517-526.
  • 10王文,刘力生.原发性高血压的实验模型[J].高血压杂志,1997,5(4):266.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部